Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR3 | P49019 | 2/20 | 0.51 |
| ▸ | XDH | P47989 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16731730 | 0.84 | ALDH1A1 (0.50) | HCAR3XDHALDH1A1HPGD | |
| SCHEMBL1110736 | 0.82 | CA1 (0.45) | XDHALDH1A1HPGDGAAMAPT | |
| SCHEMBL20587133 | 0.82 | ALDH1A1 (0.42) | HCAR3XDHALDH1A1HPGD | |
| SCHEMBL3711554 | 0.79 | GAA (0.40) | HCAR3XDHALDH1A1HPGDGAA | |
| SCHEMBL13722439 | 0.79 | XDH (0.56) | XDHKDM4E | |
| SCHEMBL29472005 | 0.77 | ALDH1A1 (0.59) | XDHALDH1A1HPGDGAAMAPT | |
| SCHEMBL4844022 | 0.77 | ALDH1A1 (0.59) | XDHALDH1A1HPGDGAAMAPT | |
| SCHEMBL31186416 | 0.77 | ALDH1A1 (0.51) | ALDH1A1HPGD | |
| SCHEMBL3959215 | 0.77 | ALDH1A1 (0.51) | ALDH1A1HPGD | |
| SCHEMBL28343052 | 0.76 | ALDH1A1 (0.50) | XDHALDH1A1HPGDGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190275181-A1 | Compounds for Positron Emission Tomography | ENDOCYTE INC (US) | 2019-09-12 | — | — | US | disclosed |
| EP-2455105-B1 | Bombesin analogues | PIRAMAL IMAGING SA (CH) | 2016-02-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190275181-A1 | Compounds for Positron Emission Tomography | FOLH1, FOLR2, FOLR1 | HCAR3 1273/4885XDH 3300/4885ALDH1A1 2485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.